🔎 Trials Near Me

Home › Blast Crisis

Pag-aaral pangklinika para sa Blast Crisis na nagre-recruit sa U.S.

10 pag-aaral para sa Blast Crisis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.

Mga lungsod na may pinakamaraming pag-aaral

Ayos sa estado

Mga pag-aaral na kamakailan lamang in-update

Opisyal na teksto ng pag-aaral (English)

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Nagre-recruitPhase 1
Edad 1 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT03630991

Asciminib Roll-over Study

Nagre-recruitPhase 4
Edad 7 hanggang 100 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04877522

Registry of Older Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral
Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT03589729

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Nagre-recruitPhase 1
Hanggang edad 80 · Lahat ng kasarian · Na-update May 18, 2026 · NCT03326921

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT07362225

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 27, 2025 · NCT01137643

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.